Here, therapy with TriCurin is presented: TriCurin for human papillomavirus-positive (HPV) head and neck squamous cell carcinoma. Head and neck tumors include a group of different types of cancer that occur in the head and neck area.

​

Over 90% of malignant tumors of this type are carcinomas of the larynx, pharynx, lip and oral cavity. These arise in the squamous epithelium of the mucous membranes and are therefore called squamous cell carcinomas.

​

Adenocarcinomas, such as carcinomas in the nose, are rarer and arise in the gland cells.

​

TriCurin, which contains epigallocatechin gallate (EGCG), could potentially help inhibit the growth of HPV-positive tumor cells and represents an innovative treatment option.